Innovating Works

ING

Desconocido
OXYTRAIN: Harnessing the power of enzymatic oxygen activation INGENZA LIMITED participó en un H2020: H2020-MSCA-ITN-2016 For the selective and effective incorporation of oxygen into biological molecules (oxygenation reaction), several enzyme types have evolved...
2016-08-29 - 2021-03-31 | Financiado
SYNBIOMAN: Demonstration of a synthetic biology driven biomanufacturing platform for adaptable cost effective p... INGENZA LIMITED tramitó un H2020: H2020-SMEInst-2016-2017 Ingenza will address an unmet industry need at the European level for an enabling biologics manufacturing and refinement platform targeting...
2016-07-27 - 2016-12-31 | Financiado
EmPowerPutida: Exploiting native endowments by re factoring re programming and implementing novel control loops in... INGENZA LIMITED participó en un H2020: H2020-BIOTEC-2014-2015 We aim to engineer the lifestyle of Pseudomonas putida to generate a tailored, re-factored chassis with highly attractive new-to-nature prop...
2015-03-13 - 2019-04-30 | Financiado
KYROBIO: The discovery development and demonstration of biocatalysts for use in the industrial synthesis of... INGENZA LIMITED participó en un FP7: The objective of KYROBIO project is to broaden the toolbox of single enantiomer chiral chemicals that are produced by industry in Europe usi...
Financiado
BIOCONSEPT: Integration of Bio Conversion and Separation Technology for the production and application of platfo... INGENZA LIMITED participó en un FP7: BioConSepT aims to demonstrate the technically feasibility of White Biotech processes for the conversion of 2nd generation biomass into pla...
Financiado
SEABIOTECH: From sea bed to test bed harvesting the potential of marine microbes for industrial biotechnology INGENZA LIMITED participó en un FP7: SeaBioTech is a 48-month project designed and driven by SMEs to create innovative marine biodiscovery pipelines as a means to convert the po...
Financiado
AMYLOMICS: AmylolEnzymes Captured by Targeted Metagenomics INGENZA LIMITED participó en un FP7: The aim of the AMYLOMICS project is to develop novel, robust enzymes for the starch and carbohydrate industries. The novel enzymes should e...
Financiado
NEWPROT: An interactive protein engineering portal with validated software and database facilities INGENZA LIMITED participó en un FP7: Two academic groups and eight SMEs who all work on different aspects of protein engineering will collaborate and produce a website that will...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.